A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain
Clinical trial NCT07598448 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07598448
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-23
- Primary completion
- 2026-12-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.